FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 104 filers reported holding FATE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4 | -63.6% | 1,482 | -8.5% | 0.00% | – |
Q1 2024 | $11 | +120.0% | 1,620 | +11.8% | 0.00% | – |
Q4 2023 | $5 | – | 1,449 | +354.2% | 0.00% | – |
Q3 2023 | $0 | -100.0% | 319 | -96.6% | 0.00% | – |
Q2 2023 | $44 | -24.1% | 9,441 | -8.7% | 0.00% | – |
Q1 2023 | $58 | +286.7% | 10,336 | +587.2% | 0.00% | – |
Q4 2022 | $15 | -100.0% | 1,504 | +10.2% | 0.00% | – |
Q3 2022 | $30,000 | +650.0% | 1,365 | +689.0% | 0.00% | – |
Q2 2022 | $4,000 | -99.0% | 173 | -98.3% | 0.00% | – |
Q1 2022 | $403,000 | +1579.2% | 10,417 | +2345.3% | 0.00% | – |
Q4 2021 | $24,000 | -96.9% | 426 | -97.8% | 0.00% | -100.0% |
Q3 2020 | $770,000 | +2466.7% | 19,284 | +1121.3% | 0.00% | – |
Q4 2019 | $30,000 | -81.4% | 1,579 | -84.8% | 0.00% | – |
Q3 2019 | $161,000 | -25.8% | 10,388 | -3.2% | 0.00% | -100.0% |
Q2 2019 | $217,000 | -32.8% | 10,730 | -41.7% | 0.00% | 0.0% |
Q1 2019 | $323,000 | +201.9% | 18,413 | +119.4% | 0.00% | – |
Q4 2018 | $107,000 | +10600.0% | 8,394 | +7263.2% | 0.00% | – |
Q3 2018 | $1,000 | -99.3% | 114 | -99.1% | 0.00% | -100.0% |
Q2 2018 | $149,000 | -48.1% | 13,165 | -55.3% | 0.00% | -92.3% |
Q1 2018 | $287,000 | +1095.8% | 29,462 | +637.7% | 0.01% | +1200.0% |
Q4 2017 | $24,000 | – | 3,994 | +3740.4% | 0.00% | – |
Q3 2017 | $0 | – | 104 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $11,083,330 | 2.77% |
Redmile Group, LLC | 13,169,057 | $43,194,507 | 2.61% |
SUPERSTRING CAPITAL MANAGEMENT LP | 497,360 | $1,631,341 | 2.06% |
Boxer Capital, LLC | 8,215,910 | $26,948,185 | 1.42% |
Deep Track Capital, LP | 5,572,607 | $18,278,151 | 0.55% |
Vestal Point Capital, LP | 2,000,000 | $6,560,000 | 0.49% |
Bruce & Co., Inc. | 300,000 | $984,000 | 0.32% |
Octagon Capital Advisors LP | 520,800 | $1,708,224 | 0.27% |
Integral Health Asset Management, LLC | 850,000 | $2,788,000 | 0.26% |
Bellevue Group AG | 4,839,779 | $15,874,475 | 0.26% |